Markets:

Overview

News

Currencies

International

Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

101.67 -0.07 (-0.07%)

Streaming Delayed Price Updated: 11:21 AM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

3 Healthcare Stocks That Could Set You Up For Life ↗

November 24, 2022

All offer products that are invaluable to their respective audiences.

Via The Motley Fool

Exact Sciences's Return On Capital Employed Insights ↗

November 22, 2022

Via Benzinga

MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences ↗

November 14, 2022

BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares...

Via Benzinga

As Cathie Wood's ARK ETF Surges, These 7 Stocks In The Fund Are Up Over 20% In 5 Days ↗

November 11, 2022

Cathie Wood, the founder, CEO and CIO of ARK Investment Management, has had a tough year in the stock market as all eight of the company's exchange-traded funds (ETFs) were down substantially lower...

Via Benzinga

Cathie Wood's ARK Innovation ETF Marks Record Surge On Thursday: Here's What She Offloaded Amid Market Rally ↗

November 11, 2022

Cathie Wood-owned ARK Investment Management’s flagship fund, the ARK Innovation ETF (NYSE: ARKK) close

Via Benzinga

Where Exact Sciences Stands With Analysts ↗

November 08, 2022

Exact Sciences (NASDAQ:EXAS) has observed the following analyst ratings within the last quarter:

Via Benzinga

Why Exact Sciences Stock Is Soaring Today ↗

November 04, 2022

Investors are reacting positively to the company's Q3 update.

Via The Motley Fool

Exact Sciences (EXAS) Q3 2022 Earnings Call Transcript ↗

November 03, 2022

EXAS earnings call for the period ending September 30, 2022.

Via The Motley Fool

Expert Ratings for Exact Sciences ↗

November 08, 2022

Over the past 3 months, 4 analysts have published their opinion on Exact Sciences (NASDAQ:EXAS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Raymond James Maintains Outperform Rating for Exact Sciences: Here's What You Need To Know ↗

November 08, 2022

Raymond James has decided to maintain its Outperform rating of Exact Sciences (NASDAQ:EXAS) and lower its price target from $70.00 to $60.00. Shares of Exact Sciences are trading up 3.28% over the last...

Via Benzinga

SolarEdge To Rally 54%? Plus This Analyst Predicts $1,335 For Mettler-Toledo International ↗

November 08, 2022

Goldman Sachs raised the price target on Mettler-Toledo International Inc. (NYSE: MTD) from $1,120 to $1,335. Goldman Sachs analyst Matthew Sykes upgraded the stock from Sell to Neutral. Mettler-Toledo...

Via Benzinga

Apple To $154? Plus This Analyst Predicts $2,650 For Booking Holdings ↗

November 07, 2022

B of A Securities cut the price target on Apple Inc. (NASDAQ: AAPL) from $160 to $154. Apple shares fell 1.5% to trade at $136.34 on Monday

Via Benzinga

5 Top Stocks Cathie Wood Is Buying This Week ↗

November 04, 2022

Cathie Wood just lauded Elon Musk's acquisition of Twitter, believing the platform will become a "super-app." Here are her top five buys.

Via InvestorPlace

Recap: Exact Sciences Q3 Earnings ↗

November 03, 2022

Exact Sciences (NASDAQ:EXAS) reported its Q3 earnings results on Thursday, November 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Exact Sciences Boosts 2022 Outlook After Crushing Third-Quarter Forecasts ↗

November 03, 2022

Exact Sciences boosted its 2022 guidance by $33 million after a strong quarter.

Via Investor's Business Daily

8 Analysts Have This to Say About Exact Sciences ↗

October 19, 2022

Analysts have provided the following ratings for Exact Sciences (NASDAQ:EXAS) within the last quarter:

Via Benzinga

Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday ↗

November 07, 2022

Gainers

Via Benzinga

Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session ↗

November 04, 2022

Gainers

Via Benzinga

Block, MasTec, Universal Display And Some Other Big Stocks Moving Higher On Friday ↗

November 04, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

2 Stocks That Could Double in the Next 5 Years ↗

October 24, 2022

These companies aren't handling the downturn well, but they can turn things around.

Via The Motley Fool

Cathie Wood's Funds Deliver Mixed Q3 Results: Ark Founder's Shares Take On Zoom, Roku, Teladoc And Blockchain ↗

October 20, 2022

Cathie Wood-led ARK Investment Management’s flagship fund ARK Innovation ETF’s (NYSE: ARKK) performance during the third quarter was mixed relative to broad-based indexes, as it outperformed the MSCI...

Via Benzinga

What 8 Analyst Ratings Have To Say About Exact Sciences ↗

October 19, 2022

Over the past 3 months, 8 analysts have published their opinion on Exact Sciences (NASDAQ:EXAS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Why Guardant Health Stock Fell 5.5% Today ↗

October 19, 2022

Is Guardant Health as obvious a bargain as this analyst makes it out to be?

Via The Motley Fool

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday ↗

October 18, 2022

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022 ↗

October 19, 2022

Upgrades

Via Benzinga

Amazon, Bank of America, Microsoft And Other Big Gainers From Monday ↗

October 18, 2022

U.S. stocks closed higher on Monday, with the Dow Jones gaining around 550 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

3 Growth Stocks That Could Double Your Money, According to Wall Street ↗

October 13, 2022

Investment bank analysts think these stocks will shoot through the roof once the rest of the market sees them in the same light.

Via The Motley Fool

3 Cathie Wood Stocks That Are Too Cheap to Ignore ↗

October 07, 2022

These Cathie Wood stocks are risky, but offer immense upside potential down the road, for those willing to take a more aggressive approach.

Via InvestorPlace

Is Illumina Still the Gamechanger in Genomics Sequencing?

October 04, 2022

Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused

Via MarketBeat

7 Cheap Cathie Wood Stocks to Buy in October ↗

October 03, 2022

Ark launched a new fund on Sept. 27. While you try to figure it out, here are 7 cheap Cathie Wood stocks to buy for October.

Via InvestorPlace

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Exact Sciences Corporation - Common Stock (NQ:EXAS)

All News about Exact Sciences Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today